Cosmo’s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal

· Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals N.V., a global leader in AI-powered healthcare and specialty pharma, today announced two major milestones in its sustainability journey, underscoring its commitment to transparency, responsible operations, and ESG leadership.

Download press release (PDF)

← All news